The Use of Reminders in Implementing an E-learning Program in General Practice

NCT ID: NCT00394017

Last Updated: 2009-10-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

339 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-11-30

Study Completion Date

2007-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate General Practitioners use and reuptake of an e-learning programme in diagnostic evaluation of dementia after an intervention consisting of three mailed reminder letters.

There is no direct patient involvement in this study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The three mailed reminder letters will be mailed to the General Practitioners (GPs) in January 2007. The Periods where the e-learning programme will identify GPs using the programme are: Period before: November 1. and 6 weeks forward. Period after: Medio marts and 6 weeks forward.

All log files are kept anonymous for the principal study investigator by the Danish Medical Association.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dementia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Reminder letters and usual implementations vs. usual implementation

Group Type ACTIVE_COMPARATOR

Reminder letters

Intervention Type BEHAVIORAL

3 mailed reminder letters

Control group

usual implementations

Group Type NO_INTERVENTION

Reminder letters

Intervention Type BEHAVIORAL

3 mailed reminder letters

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reminder letters

3 mailed reminder letters

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* General Practitioners working in Copenhagen Municipality October 1st 2006

Exclusion Criteria

* General Practitioners stopping to work in study period
Minimum Eligible Age

30 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of the Interior and Health, Denmark

OTHER_GOV

Sponsor Role collaborator

Research Unit Of General Practice, Copenhagen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Research Unit Of General Practice, Copenhagen

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Frans B Waldorff, PhD

Role: PRINCIPAL_INVESTIGATOR

Research Unit of General Practice

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Unit of General Practice

Copenhagen, Capital Province, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CPH-06-01-FEAP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Dementia Study in Northern Norway
NCT00443014 COMPLETED PHASE4